The FDA has approved relacorilant (Lifyorli, Corcept Therapeutics) in combination with nab-paclitaxel for adults with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal ...

Join Drs Steven Feldman and Bernard Vrijens as they discuss the theory and practice of improving treatment adherence for ...

Most clinicians take no preventive action when a low-risk patient presents with elevated levels of lipoprotein(a), but 1 in 5 ...

Limited numeracy affects how patients interpret risk and treatment benefits, highlighting the need for clear, structured ...

AI-based screening for glaucoma can be implemented in primary care within existing screening programmes, enhancing efficiency ...

Colon cleansing claims are unsupported by evidence, while adverse effects, including hyponatremia, hypokalemia, and ...

From 19th century ‘white blood’ observations and pathological anatomy to the discovery of BCR-ABL and imatinib, leukemia care ...

METHODOLOGY: A prospective, open-label, single-arm study enrolled eight pediatric patients (62.5% female; median age, 16 years) with SLE who had MAS and had an inadequate response ...

Minimally invasive olfactory brush biopsy flags biological signals of Alzheimer’s disease years before memory loss occurs.

A new analysis evaluates how acquisition prices, reimbursement prices, and adoption of oncology biosimilars have shifted.

Early eptinezumab responders continue to experience strong reductions in monthly migraine days across 72 weeks, with ...

In a new policy document, the UN recommends shifting the burden of proof for pollution-related harms to health from ...